Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial.
作者信息
von Tresckow Julia, Cramer Paula, Robrecht Sandra, Langerbeins Petra, Fink Anna-Maria, Al-Sawaf Othman, Fürstenau Moritz, Illmer Thomas, Klaproth Holger, Tausch Eugen, Ritgen Matthias, Fischer Kirsten, Wendtner Clemens-Martin, Kreuzer Karl-Anton, Stilgenbauer Stephan, Böttcher Sebastian, Eichhorst Barbara F, Hallek Michael
机构信息
Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, German CLL Study Group, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
Clinic for Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
出版信息
Leukemia. 2022 Aug;36(8):2125-2128. doi: 10.1038/s41375-022-01629-7. Epub 2022 Jun 25.
Zotero 插件